Effect of Vitamin B6 Versus Propranolol on Antipsychotic-Induced Akathisia: A pilot Comparative Double-blind Study

AuthorNarges Shams-Alizadeh
AuthorHamid Bakhshayesh
AuthorFarzin Rezaei
AuthorEbrahim Ghaderi
AuthorNasim Shams-Alizadeh
AuthorKambiz Hassanzadeh
Issued Date2018-03-31
AbstractAkathisia is a common adverse effect of antipsychotic drugs and is characterized by subjective feelings of restlessness. First-line treatment usually consists of propranolol, a beta adrenergic antagonist. However, propranolol does not seem to be efficacious in up to 70% of patients. This study was aimed to evaluate the effect of vitamin B6 versus propranolol on antipsychotic-induced akathisia (AIA). This study was a comparative, double-blind, randomized trial. In the present study, 66 adult patients with antipsychotic-induced akathisia were enrolled and randomized into three groups, and received vitamin B6 300 mg/12 h or 600 mg/12 h or propranolol 20 mg/12 h. The diagnosis of AIA was made by clinical examination and its severity was assessed by the Barnes Akathisia Rating Scale.
DOIhttps://doi.org/10.22037/ijpr.2018.2205
KeywordAntipsychotic
KeywordAkathisia
KeywordClinical trial
KeywordPropranolol
KeywordVitamin B6
PublisherBrieflands
TitleEffect of Vitamin B6 Versus Propranolol on Antipsychotic-Induced Akathisia: A pilot Comparative Double-blind Study
TypeOriginal Article_imported
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-17-130.pdf
Size:
437.95 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF